Pandemic ready: How to rapidly scale up liquid handling in diagnostic labs

· Customer Testimonial

Pandemic ready: How to rapidly scale up liquid handling in diagnostic labs

The COVID-19 crisis has led to unparalleled pressure on labs to ramp up capacity for testing for the SARS-CoV-2 virus. Many labs turned to electronic pipettes and pipetting robots to help tackle the challenge of increasing testing capacity while, at the same time, enhancing the reproducibility of results. Our portfolio of liquid handling products has been used across a whole host of COVID-19-related workflows worldwide. So, how does INTEGRA help?

PCR testing and serology workflows using INTEGRA's range of liquid handling products

Nucleic acid extraction

After reformatting, nucleic acid extraction is required before PCR – the go-to method to test for the presence of the SARS-CoV-2 virus. The VIAFLO 96/384 handheld electronic pipette is an ideal option for boosting throughput when adding buffers or samples to 96 or 384 wells in parallel, and is perfect to use with a with range of extraction methods, including a number of magnetic bead purification protocols, as well as various silica-based kits using vacuum manifolds. California-based medical device company Neoteryx LLC depends on this flexible instrument to reliably and reproducibly process thousands of samples per day as an integral part of its new high throughput biological sample collection and processing system for quantifying undetected cases of coronavirus infections in the United States.

Futureproof systems for life before, during and after COVID-19

Our portfolio of products is perfect for laboratories that have had to adjust their workflows to meet urgent COVID-19 demands, requiring rapid implementation and scale-up of new and existing processes. Luckily, with our family of products, there is something to help every workflow and this crisis has been an extreme demonstration of their versatility.

Rate this article

CAPTCHA